Bähr, O., Hattingen, E., Rieger, J., & Steinbach, J. P. (2011). Bevacizumab-induced tumor calcifications as a surrogate marker of outcome in patients with glioblastoma. Oxford University Press.
Chicago-стиль цитированияBähr, Oliver, Elke Hattingen, Johannes Rieger, and Joachim P. Steinbach. Bevacizumab-induced Tumor Calcifications As a Surrogate Marker of Outcome in Patients With Glioblastoma. Oxford University Press, 2011.
MLA-цитированиеBähr, Oliver, Elke Hattingen, Johannes Rieger, and Joachim P. Steinbach. Bevacizumab-induced Tumor Calcifications As a Surrogate Marker of Outcome in Patients With Glioblastoma. Oxford University Press, 2011.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.